agilon health, inc. Payments to Acquire Marketable Securities
agilon health, inc. (AGL) reported Payments to Acquire Marketable Securities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-05
- agilon health, inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $0.00.
- agilon health, inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $0.00.
- agilon health, inc. payments to acquire marketable securities for fiscal 2025 was $60.15M, a 401.03% increase from fiscal 2024.
- agilon health, inc. payments to acquire marketable securities for fiscal 2024 was $12.01M, a 89.53% decline from fiscal 2023.
- agilon health, inc. payments to acquire marketable securities for fiscal 2023 was $114.66M, a 74.98% decline from fiscal 2022.
- agilon health, inc. payments to acquire marketable securities for fiscal 2022 was $458.26M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $12.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $12.64M derived: sum of 3 quarters · filed 2026-08-05 | $60.15M 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $12.64M derived: sum of 2 quarters · filed 2026-08-05 | $60.15M 10-Q · filed 2025-11-04 | $60.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $12.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $60.15M 10-Q · filed 2026-08-05 | $60.15M derived: sum of 3 quarters · filed 2026-08-05 | $60.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $47.52M 10-Q · filed 2026-05-06 | $47.52M derived: sum of 2 quarters · filed 2026-05-06 | $47.52M derived: sum of 3 quarters · filed 2026-05-06 | $59.52M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $12.01M derived: sum of 3 quarters · filed 2026-02-25 | $12.01M 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $12.01M derived: sum of 2 quarters · filed 2025-11-04 | $12.01M 10-Q · filed 2025-11-04 | $19.64M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $12.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $12.01M 10-Q · filed 2025-08-04 | $19.64M derived: sum of 3 quarters · filed 2026-02-25 | $61.09M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $7.64M derived: sum of 2 quarters · filed 2026-02-25 | $49.09M derived: sum of 3 quarters · filed 2026-02-25 | $84.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $7.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $49.09M derived: sum of 2 quarters · filed 2026-02-25 | $84.69M derived: sum of 3 quarters · filed 2026-02-25 | $114.66M 10-K · filed 2026-02-25 |
| 2023-09-30 | $41.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $77.05M derived: sum of 2 quarters · filed 2024-11-07 | $107.02M 10-Q · filed 2024-11-07 | $142.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $35.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $65.57M 10-Q · filed 2024-08-06 | $100.65M derived: sum of 3 quarters · filed 2025-02-25 | $238.76M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $29.97M 10-Q · filed 2024-05-07 | $65.05M derived: sum of 2 quarters · filed 2025-02-25 | $203.16M derived: sum of 3 quarters · filed 2025-02-25 | $488.23M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $35.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $173.19M derived: sum of 2 quarters · filed 2025-02-25 | $458.26M derived: sum of 3 quarters · filed 2025-02-25 | $458.26M 10-K · filed 2025-02-25 |
| 2022-09-30 | $138.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $423.18M derived: sum of 2 quarters · filed 2023-11-02 | $423.18M 10-Q · filed 2023-11-02 | $423.18M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $285.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $285.08M 10-Q · filed 2023-08-03 | $285.08M derived: sum of 3 quarters · filed 2024-02-27 | $285.08M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |